\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\:\\ 109\\/75\\,\\ \\ \\ \\ \\ hr\\:\\ 111\\,\\ \\ \\ \\ \\ rr\\:\\ 14\\,\\ \\ \\ \\ \\ t\\:\\ 97\\.8\\ \\Â\\°f\\,\\ \\ \\ \\ \\ ht\\:\\ 72\\ in\\,\\ \\ \\ \\ \\ wt\\:\\ 176\\ lbs\ \(0\)\
\-\ general\\ appearance\\:\ \(0\)\
\-\ \\Â\\°\\ normal\\.\\ \\ \\Â\\°\\ well\\ developed\\.\\ \\ \\Â\\°\\ well\\ nourished\\.\\ \\ \\Â\\°\\ in\\ no\\ acute\\ distress\\.\ \(0\)\
\-\ head\\:\ \(5\)\
\-\ injuries\\:\\ \\Â\\°\\ no\\ evidence\\ of\\ a\\ head\\ injury\\.\ \(0\)\
\-\ appearance\\:\\ \\Â\\°\\ head\\ normocephalic\\.\ \(0\)\
\-\ eyes\\:\ \(0\)\
\-\ pupils\\:\\ \\Â\\°\\ perrl\\.\\ \\ \\Â\\°\\ size\\ of\\ the\\ pupil\\ was\\ normal\\.\\ \\ \\Â\\°\\ pupil\\ accommodation\\ was\\ not\\ impaired\\.\ \(0\)\
\-\ external\\:\\ \\Â\\°\\ eyelids\\ showed\\ no\\ abnormalities\\.\\ \\ \\Â\\°\\ conjunctiva\\ exhibited\\ no\\ abnormalities\\.\ \(0\)\
\-\ sclera\\:\\ \\Â\\°\\ normal\\.\ \(0\)\
\-\ musculoskeletal\\ system\\:\\ nml\ \(0\)\
\-\ functional\\ exam\\:\ \(0\)\
\-\ general\\/bilateral\\:\\ \\Â\\°\\ mobility\\ was\\ not\\ limited\\.\ \(0\)\
\-\ neurological\\:\ \(0\)\
\-\ \\Â\\°\\ oriented\\ to\\ time\\,\\ place\\,\\ and\\ person\\.\ \(0\)\
\-\ cranial\\ nerves\\:\\ \\Â\\°\\ normal\\.\ \(0\)\
\-\ balance\\:\\ \\Â\\°\\ normal\\.\\ \\ \\Â\\°\\ romberg\\'s\\ sign\\ was\\ absent\\.\ \(0\)\
\-\ gait\\ and\\ stance\\:\\ \\Â\\°\\ normal\\.\ \(0\)\
\-\ trans\\-sphenoidal\\ resection\\ of\\ pituitary\\ adenoma\\.\\ 6\\ month\\ post\\-op\\ mri\\ showed\\ empty\\ sella\\ with\\ trace\\ residual\\ pituitary\\ parenchyma\\ along\\ the\\ lateral\\ margins\\.\\ 6\\ month\\ postop\\ visual\\ field\\ testing\\ showed\\ complete\\ return\\ of\\ visual\\ fields\\ and\\ left\\ eye\\,\\ but\\ residual\\ temporal\\ hemianopsia\\ of\\ the\\ right\\ eye\\ with\\ minimal\\ return\\ of\\ central\\ vision\\ on\\ the\\ right\\.\ \(0\)\
\-\ as\\ clinically\\ suspected\\,\\ there\\ is\\ a\\ large\\ suprasellar\\ mass\\ which\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ measures\\ approximately\\ 39\\ mm\\ cc\\ x\\ 24\\ mm\\ tr\\ x\\ 23\\ mm\\ ap\\.\\ 50\\%\\ of\\ the\\ mass\\ is\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ suprasellar\\ and\\ 50\\%\\ is\\ within\\ the\\ sella\\.\\ as\\ such\\,\\ the\\ mass\\ shape\\ is\\ somewhat\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ dumbbell\\ in\\ morphology\\.\\ the\\ sella\\ appears\\ expanded\\.\\ the\\ mass\\ signal\\ intensity\\ is\\	\ \(0\)\
\-\ \\ \\ \\ \\ mixed\\ with\\ multiple\\ globular\\ sites\\ of\\ t2\\ and\\ t1\\ hyperintensity\\ measuring\\ on\\ the\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ order\\ of\\ 8\\ mm\\ interposed\\ with\\ solid\\ appearing\\,\\ isointense\\ to\\ brain\\ parenchyma\\ \\	\ \(1\)\
\-\ \\ \\ \\ \\ tissue\\ mostly\\ compatible\\ with\\ areas\\ of\\ cystic\\ degeneration\\ with\\ or\\ without\\ some\\ \\	\ \(1\)\
\-\ \\ \\ \\ \\ degree\\ of\\ hemorrhage\\.\\ there\\ is\\ superior\\ mass\\ effect\\ upon\\ the\\ optic\\ chiasm\\.\\ \\	\\	\ \(0\)\
\-\ \\ \\ \\ \\ in\\ other\\ regards\\,\\ the\\ brainstem\\,\\ cerebellum\\,\\ and\\ cerebral\\ hemispheres\\ are\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ otherwise\\ normal\\ in\\ morphology\\ without\\ evidence\\ of\\ other\\ abnormal\\ enhancement\\,\\ \\	\ \(1\)\
\-\ \\ \\ \\ \\ other\\ mass\\ lesion\\,\\ hemorrhage\\,\\ midline\\ shift\\,\\ or\\ ischemia\\.\\ gray\\-white\\ matter\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ differentiation\\ is\\ appropriate\\.\\ specifically\\,\\ no\\ abnormal\\ t2\\ or\\ flair\\ signal\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ alteration\\ is\\ present\\ and\\ no\\ restricted\\ diffusion\\ is\\ identified\\.\\ \\	\\	\ \(1\)\
\-\ \\ \\ \\ \\ the\\ ventricles\\,\\ basal\\ cisterns\\,\\ and\\ sulci\\ are\\ appropriate\\ volume\\ for\\ the\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ patient\\'s\\ age\\.\\ no\\ abnormal\\ extra\\-axial\\ fluid\\ or\\ mass\\ lesion\\ is\\ present\\.\\ \\	\\	\ \(0\)\
\-\ \\ \\ \\ \\ the\\ orbital\\ contents\\ are\\ unremarkable\\.\\ no\\ discrete\\ middle\\ ear\\ abnormality\\ is\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ appreciated\\.\\ \\	\\	\ \(1\)\
\-\ \\ \\ \\ \\ the\\ visualized\\ paranasal\\ sinuses\\ and\\ mastoid\\ air\\ cells\\ are\\ clear\\.\\ the\\ remainder\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ of\\ the\\ visualized\\ soft\\ tissues\\ and\\ osseous\\ structures\\ are\\ normal\\.\\ \\	\\	\ \(1\)\
\-\ \\ \\ \\ \\ impression\\:\\ findings\\ essentially\\ diagnostic\\ large\\ 4\\ cm\\ pituitary\\ macroadenoma\\.\ \(0\)\
\-\ pituitary\\ macroadenoma\ \(8\)\
\-\ pituitary\\ macroadenoma\\,\\ pituitary\\ carcinoma\\,\\ meningioma\\,\\ craniopharyngioma\\,\\ lymphocytic\\ hypophysitis\ \(0\)\
\-\ 23\\ yo\\ man\\ presented\\ to\\ the\\ clinic\\ for\\ required\\ annual\\ physical\\.\\ \\ patient\\ had\\ obvious\\ visual\\ field\\ defects\\ in\\ the\\ lateral\\ fields\\.\\ \\ visual\\ field\\ mapping\\ was\\ then\\ done\\ with\\ optometry\\ the\\ same\\ day\\ which\\ showed\\ bitemporal\\ hemianopsia\\.\ \(0\)\
\-\ pituitary\\ macroadenomas\\ are\\ benign\\ epithelial\\ neoplasms\\ composed\\ of\\ adenohypophysial\\ cells\\ and\\ account\\ for\\ 10\\-15\\%\\ of\\ all\\ intracranial\\ tumors\\.\\ tumors\\ exceeding\\ 10\\ mm\\ are\\ defined\\ as\\ macroadenomas\\,\\ and\\ those\\ smaller\\ than\\ 10\\ mm\\ are\\ termed\\ microadenomas\\.\\ most\\ pituitary\\ adenomas\\ are\\ microadenomas\\.\\ \\ morbidity\\ \\ varies\\ from\\ incidentally\\ discovered\\ nonfunctioning\\ tumors\\ to\\ disabling\\ macroadenomas\\.\\ morbidity\\ results\\ from\\ mass\\ effect\\,\\ hormonal\\ imbalance\\,\\ and\\ patient\\ comorbidities\\.\\ women\\ of\\ childbearing\\ age\\ are\\ diagnosed\\ more\\ frequently\\ with\\ pituitary\\ adenomas\\ as\\ compared\\ to\\ men\\,\\ possibly\\ due\\ to\\ presenting\\ complaint\\ of\\ amenorrhea\\.\\ incidence\\ increases\\ with\\ age\\,\\ peaking\\ between\\ the\\ third\\ and\\ sixth\\ decades\\.\\ patients\\ with\\ pituitary\\ macroadenomas\\ may\\ be\\ asymptomatic\\ or\\ may\\ present\\ with\\ complaints\\ due\\ to\\ hormonal\\ imbalance\\ or\\ mass\\ effects\\,\\ such\\ as\\ visual\\ deficits\\,\\ headache\\,\\ elevated\\ intracranial\\ pressure\\,\\ or\\ intracranial\\ hemorrhage\\ \ \(0\)\
\-\ mulinda\\,\\ jr\\.\\ pituitary\\ macroadenomas\\.\\ www\\.emedicine\\.com\\/med\\/topic1379\\.htm\\.\\ accessed\\ on\\ june\\ 12\\,\\ 2017\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pituitary\\:\\ 0\\.3815719600182752\ \(0\)\
\-\ macroadenomas\\:\\ 0\\.28733599187630793\ \(0\)\
\-\ the\\:\\ 0\\.16508284114413754\ \(0\)\
\-\ mm\\:\\ 0\\.16147643298026193\ \(0\)\
\-\ visual\\:\\ 0\\.16042546545898725\ \(0\)\
\-\ are\\:\\ 0\\.14269777843754955\ \(0\)\
\-\ macroadenoma\\:\\ 0\\.13046807111183442\ \(0\)\
\-\ mass\\:\\ 0\\.1292804939500457\ \(0\)\
\-\ of\\:\\ 0\\.1251086695102015\ \(0\)\
\-\ normal\\:\\ 0\\.12283431714925776\ \(0\)\
\-\ sella\\:\\ 0\\.11675934884926874\ \(0\)\
\-\ is\\:\\ 0\\.11328533310313199\ \(0\)\
\-\ and\\:\\ 0\\.10879155792070924\ \(0\)\
\-\ microadenomas\\:\\ 0\\.10819915898552904\ \(0\)\
\-\ field\\:\\ 0\\.10603352713682676\ \(0\)\
\-\ imbalance\\:\\ 0\\.10579524857547938\ \(0\)\
\-\ showed\\:\\ 0\\.10019309836955533\ \(0\)\
\-\ no\\:\\ 0\\.09783242280681888\ \(0\)\
\-\ pupil\\:\\ 0\\.09560073699959305\ \(0\)\
\-\ hormonal\\:\\ 0\\.0928630111963266\ \(0\)\
\-\ or\\:\\ 0\\.09157727599720679\ \(0\)\
\-\ intracranial\\:\\ 0\\.09077717160989772\ \(0\)\
\-\ hemianopsia\\:\\ 0\\.08807810090110581\ \(0\)\
\-\ adenomas\\:\\ 0\\.0875169522253918\ \(0\)\
\-\ tumors\\:\\ 0\\.08297189610755942\ \(0\)\
\-\ with\\:\\ 0\\.08100103770674372\ \(0\)\
\-\ morbidity\\:\\ 0\\.08078171446039766\ \(0\)\
\-\ morphology\\:\\ 0\\.08013841596285642\ \(0\)\
\-\ as\\:\\ 0\\.07553838330322106\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.07553454093128154\ \(0\)\
\-\ fields\\:\\ 0\\.07398071594187675\ \(0\)\
\-\ suprasellar\\:\\ 0\\.07378537898024183\ \(0\)\
\-\ age\\:\\ 0\\.07082831264750142\ \(0\)\
\-\ return\\:\\ 0\\.07008959651852804\ \(0\)\
\-\ residual\\:\\ 0\\.06843932000930703\ \(0\)\
\-\ abnormal\\:\\ 0\\.06777959671010057\ \(0\)\
\-\ head\\:\\ 0\\.06728718524284996\ \(0\)\
\-\ appropriate\\:\\ 0\\.06607856840620606\ \(0\)\
\-\ 10\\:\\ 0\\.06597028807017045\ \(0\)\
\-\ to\\:\\ 0\\.06581003435626229\ \(0\)\
\-\ was\\:\\ 0\\.06553036780836517\ \(0\)\
\-\ 23\\:\\ 0\\.06201802573663152\ \(0\)\
\-\ parenchyma\\:\\ 0\\.06109776835377135\ \(0\)\
\-\ general\\:\\ 0\\.06037709697948592\ \(0\)\
\-\ eye\\:\\ 0\\.06016835905123463\ \(0\)\
\-\ adenohypophysial\\:\\ 0\\.060140227860728986\ \(0\)\
\-\ mulinda\\:\\ 0\\.060140227860728986\ \(0\)\
\-\ visualized\\:\\ 0\\.058730946586321144\ \(0\)\
\-\ other\\:\\ 0\\.05858824447858279\ \(0\)\
\-\ cells\\:\\ 0\\.057949829603629155\ \(0\)\
\-\ present\\:\\ 0\\.05789062527659929\ \(0\)\
\-\ peaking\\:\\ 0\\.05746719837526159\ \(0\)\
\-\ in\\:\\ 0\\.05613095786010689\ \(0\)\
\-\ 176\\:\\ 0\\.05557065377320709\ \(0\)\
\-\ hypophysitis\\:\\ 0\\.05557065377320709\ \(0\)\
\-\ optometry\\:\\ 0\\.05557065377320709\ \(0\)\
\-\ abnormalities\\:\\ 0\\.05448158335023345\ \(0\)\
\-\ postop\\:\\ 0\\.05409957949276452\ \(0\)\
\-\ amenorrhea\\:\\ 0\\.05409957949276452\ \(0\)\
\-\ stance\\:\\ 0\\.05289762428773969\ \(0\)\
\-\ effect\\:\\ 0\\.052760271030904\ \(0\)\
\-\ 50\\:\\ 0\\.05252621156346302\ \(0\)\
\-\ dumbbell\\:\\ 0\\.051881385641939406\ \(0\)\
\-\ exceeding\\:\\ 0\\.0510010796856852\ \(0\)\
\-\ nonfunctioning\\:\\ 0\\.0510010796856852\ \(0\)\
\-\ childbearing\\:\\ 0\\.0510010796856852\ \(0\)\
\-\ accommodation\\:\\ 0\\.05022459480227229\ \(0\)\
\-\ globular\\:\\ 0\\.05022459480227229\ \(0\)\
\-\ disabling\\:\\ 0\\.05022459480227229\ \(0\)\
\-\ eyelids\\:\\ 0\\.04953000540524262\ \(0\)\
\-\ comorbidities\\:\\ 0\\.04953000540524262\ \(0\)\
\-\ tr\\:\\ 0\\.04890167286617197\ \(0\)\
\-\ interposed\\:\\ 0\\.04890167286617197\ \(0\)\
\-\ mapping\\:\\ 0\\.04890167286617197\ \(0\)\
\-\ such\\:\\ 0\\.0483802295848796\ \(0\)\
\-\ conjunctiva\\:\\ 0\\.0483280502002178\ \(0\)\
\-\ romberg\\:\\ 0\\.0483280502002178\ \(0\)\
\-\ regards\\:\\ 0\\.0483280502002178\ \(0\)\
\-\ exhibited\\:\\ 0\\.046856975919775216\ \(0\)\
\-\ perrl\\:\\ 0\\.046031837665164714\ \(0\)\
\-\ bitemporal\\:\\ 0\\.046031837665164714\ \(0\)\
\-\ month\\:\\ 0\\.04575236468230037\ \(0\)\
\-\ 2017\\:\\ 0\\.04565502071475039\ \(0\)\
\-\ appearance\\:\\ 0\\.04534243517518967\ \(0\)\
\-\ expanded\\:\\ 0\\.045298582457147754\ \(0\)\
\-\ sclera\\:\\ 0\\.04496043131772072\ \(0\)\
\-\ nml\\:\\ 0\\.044638782068950104\ \(0\)\
\-\ paranasal\\:\\ 0\\.044638782068950104\ \(0\)\
\-\ alteration\\:\\ 0\\.04433209877865007\ \(0\)\
\-\ ht\\:\\ 0\\.044039050450552904\ \(0\)\
\-\ termed\\:\\ 0\\.044039050450552904\ \(0\)\
\-\ trace\\:\\ 0\\.04348935703727814\ \(0\)\
\-\ sixth\\:\\ 0\\.04348935703727814\ \(0\)\
\-\ t2\\:\\ 0\\.04327157356608648\ \(0\)\
\-\ due\\:\\ 0\\.04323330066911066\ \(0\)\
\-\ varies\\:\\ 0\\.04323079441227463\ \(0\)\
\-\ jr\\:\\ 0\\.04323079441227463\ \(0\)\
\-\ june\\:\\ 0\\.04323079441227463\ \(0\)\
\-\ empty\\:\\ 0\\.04298199122928299\ \(0\)\
\-\ impaired\\:\\ 0\\.042742237466895615\ \(0\)\
\-\ evidence\\:\\ 0\\.04269047722740991\ \(0\)\
\-\ signal\\:\\ 0\\.04263557775704547\ \(0\)\
\-\ person\\:\\ 0\\.0425108978752421\ \(0\)\
\-\ decades\\:\\ 0\\.0425108978752421\ \(0\)\
\-\ accessed\\:\\ 0\\.0425108978752421\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.04228740183225332\ \(0\)\
\-\ mobility\\:\\ 0\\.04207123486381044\ \(0\)\
\-\ wt\\:\\ 0\\.04186193151064141\ \(0\)\
\-\ cisterns\\:\\ 0\\.041085446627228496\ \(0\)\
\-\ 111\\:\\ 0\\.04090481883851911\ \(0\)\
\-\ normocephalic\\:\\ 0\\.04090481883851911\ \(0\)\
\-\ balance\\:\\ 0\\.04090481883851911\ \(0\)\
\-\ composed\\:\\ 0\\.04090481883851911\ \(0\)\
\-\ epithelial\\:\\ 0\\.04039085723019883\ \(0\)\
\-\ chiasm\\:\\ 0\\.03991408313313082\ \(0\)\
\-\ without\\:\\ 0\\.039671533253541565\ \(0\)\
\-\ increases\\:\\ 0\\.039469476363031004\ \(0\)\
\-\ mostly\\:\\ 0\\.03932769666478675\ \(0\)\
\-\ effects\\:\\ 0\\.03905296933562793\ \(0\)\
\-\ discrete\\:\\ 0\\.038919782949756246\ \(0\)\
\-\ lbs\\:\\ 0\\.03878923409217541\ \(0\)\
\-\ mastoid\\:\\ 0\\.03878923409217541\ \(0\)\
\-\ sulci\\:\\ 0\\.03866122032475273\ \(0\)\
\-\ nourished\\:\\ 0\\.03853564506369225\ \(0\)\
\-\ account\\:\\ 0\\.03829145041068559\ \(0\)\
\-\ men\\:\\ 0\\.03829145041068559\ \(0\)\
\-\ essentially\\:\\ 0\\.03805597888415846\ \(0\)\
\-\ brainstem\\:\\ 0\\.0379413237877202\ \(0\)\
\-\ may\\:\\ 0\\.037849079576744146\ \(0\)\
\-\ specifically\\:\\ 0\\.037828628703746224\ \(0\)\
\-\ large\\:\\ 0\\.037684974970281955\ \(0\)\
\-\ compatible\\:\\ 0\\.03760885829062492\ \(0\)\
\-\ contents\\:\\ 0\\.03760885829062492\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.03750166077628854\ \(0\)\
\-\ lateral\\:\\ 0\\.03732609302246185\ \(0\)\
\-\ pupils\\:\\ 0\\.03729235742311951\ \(0\)\
\-\ functional\\:\\ 0\\.036892689490120915\ \(0\)\
\-\ sites\\:\\ 0\\.03670158909893114\ \(0\)\
\-\ patient\\:\\ 0\\.036694060491424936\ \(0\)\
\-\ impression\\:\\ 0\\.03660807686614987\ \(0\)\
\-\ eyes\\:\\ 0\\.036515872539706604\ \(0\)\
\-\ hemispheres\\:\\ 0\\.036515872539706604\ \(0\)\
\-\ differentiation\\:\\ 0\\.036515872539706604\ \(0\)\
\-\ cc\\:\\ 0\\.03642494003768611\ \(0\)\
\-\ well\\:\\ 0\\.03641804963190642\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.03633524475099721\ \(0\)\
\-\ 72\\:\\ 0\\.036246753464288836\ \(0\)\
\-\ lesion\\:\\ 0\\.036058334124776624\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.03565849704787521\ \(0\)\
\-\ shape\\:\\ 0\\.03565849704787521\ \(0\)\
\-\ sinuses\\:\\ 0\\.03542161520967834\ \(0\)\
\-\ possibly\\:\\ 0\\.03534450904560892\ \(0\)\
\-\ nerves\\:\\ 0\\.03511845826440757\ \(0\)\
\-\ neoplasms\\:\\ 0\\.03504479825926402\ \(0\)\
\-\ degeneration\\:\\ 0\\.03497195219348504\ \(0\)\
\-\ obvious\\:\\ 0\\.03497195219348504\ \(0\)\
\-\ order\\:\\ 0\\.03475812257726485\ \(0\)\
\-\ annual\\:\\ 0\\.03475812257726485\ \(0\)\
\-\ rr\\:\\ 0\\.0345510112446896\ \(0\)\
\-\ cerebellum\\:\\ 0\\.0345510112446896\ \(0\)\
\-\ discovered\\:\\ 0\\.03428461128742755\ \(0\)\
\-\ somewhat\\:\\ 0\\.03421966000465351\ \(0\)\
\-\ ear\\:\\ 0\\.03421966000465351\ \(0\)\
\-\ which\\:\\ 0\\.03419967145757465\ \(0\)\
\-\ for\\:\\ 0\\.0341942966871216\ \(0\)\
\-\ on\\:\\ 0\\.0340729991242922\ \(0\)\
\-\ isointense\\:\\ 0\\.03402855961346373\ \(0\)\
\-\ oriented\\:\\ 0\\.03390416909530788\ \(0\)\
\-\ place\\:\\ 0\\.03390416909530788\ \(0\)\
\-\ appreciated\\:\\ 0\\.03390416909530788\ \(0\)\
\-\ smaller\\:\\ 0\\.033842843054239194\ \(0\)\
\-\ women\\:\\ 0\\.033842843054239194\ \(0\)\
\-\ testing\\:\\ 0\\.033782082238178364\ \(0\)\
\-\ remainder\\:\\ 0\\.03309354378409304\ \(0\)\
\-\ shift\\:\\ 0\\.03303928420310303\ \(0\)\
\-\ ventricles\\:\\ 0\\.03303928420310303\ \(0\)\
\-\ volume\\:\\ 0\\.03303928420310303\ \(0\)\
\-\ orbital\\:\\ 0\\.0329854675624078\ \(0\)\
\-\ degree\\:\\ 0\\.032879134581791765\ \(0\)\
\-\ injuries\\:\\ 0\\.03277448949771571\ \(0\)\
\-\ gait\\:\\ 0\\.03257005445384487\ \(0\)\
\-\ vision\\:\\ 0\\.03257005445384487\ \(0\)\
\-\ ischemia\\:\\ 0\\.03257005445384487\ \(0\)\
\-\ complaint\\:\\ 0\\.03257005445384487\ \(0\)\
\-\ defects\\:\\ 0\\.03242078388341648\ \(0\)\
\-\ optic\\:\\ 0\\.03237176877379661\ \(0\)\
\-\ incidence\\:\\ 0\\.03237176877379661\ \(0\)\
\-\ hr\\:\\ 0\\.03232311540259902\ \(0\)\
\-\ restricted\\:\\ 0\\.03232311540259902\ \(0\)\
\-\ deficits\\:\\ 0\\.03232311540259902\ \(0\)\
\-\ basal\\:\\ 0\\.03217927329173822\ \(0\)\
\-\ those\\:\\ 0\\.03217927329173822\ \(0\)\
\-\ margins\\:\\ 0\\.032085093091797454\ \(0\)\
\-\ incidentally\\:\\ 0\\.03203850277862798\ \(0\)\
\-\ flair\\:\\ 0\\.031992239417717595\ \(0\)\
\-\ diffusion\\:\\ 0\\.031677179376766944\ \(0\)\
\-\ clinic\\:\\ 0\\.031677179376766944\ \(0\)\
\-\ clinically\\:\\ 0\\.03125170905515503\ \(0\)\
\-\ 39\\:\\ 0\\.03125170905515503\ \(0\)\
\-\ mixed\\:\\ 0\\.031129244198433943\ \(0\)\
\-\ frequently\\:\\ 0\\.03096941814343726\ \(0\)\
\-\ complaints\\:\\ 0\\.03096941814343726\ \(0\)\
\-\ neurological\\:\\ 0\\.03089093505134216\ \(0\)\
\-\ absent\\:\\ 0\\.03085204112215644\ \(0\)\
\-\ suspected\\:\\ 0\\.030813375311169157\ \(0\)\
\-\ cranial\\:\\ 0\\.030736717448883268\ \(0\)\
\-\ measures\\:\\ 0\\.03066094073096666\ \(0\)\
\-\ bp\\:\\ 0\\.0305119512966766\ \(0\)\
\-\ external\\:\\ 0\\.030402378105963145\ \(0\)\
\-\ compared\\:\\ 0\\.030402378105963145\ \(0\)\
\-\ distress\\:\\ 0\\.030294596383032734\ \(0\)\
\-\ appearing\\:\\ 0\\.030049753850130208\ \(0\)\
\-\ limited\\:\\ 0\\.030015507010127396\ \(0\)\
\-\ osseous\\:\\ 0\\.030015507010127396\ \(0\)\
\-\ adenoma\\:\\ 0\\.029981437157167706\ \(0\)\
\-\ there\\:\\ 0\\.02992664477497163\ \(0\)\
\-\ done\\:\\ 0\\.029913821160584133\ \(0\)\
\-\ from\\:\\ 0\\.029871041092141788\ \(0\)\
\-\ same\\:\\ 0\\.02974775439794907\ \(0\)\
\-\ not\\:\\ 0\\.029691931703865932\ \(0\)\
\-\ tissues\\:\\ 0\\.029650085917131617\ \(0\)\
\-\ upon\\:\\ 0\\.029585768315511053\ \(0\)\
\-\ presenting\\:\\ 0\\.029458985525941842\ \(0\)\
\-\ results\\:\\ 0\\.02930386067764445\ \(0\)\
\-\ measuring\\:\\ 0\\.029092641178007916\ \(0\)\
\-\ temporal\\:\\ 0\\.028887979451359604\ \(0\)\
\-\ solid\\:\\ 0\\.02883065298687118\ \(0\)\
\-\ system\\:\\ 0\\.028689480528702432\ \(0\)\
\-\ minimal\\:\\ 0\\.028689480528702432\ \(0\)\
\-\ diagnostic\\:\\ 0\\.028661605214972106\ \(0\)\
\-\ matter\\:\\ 0\\.028633847271331333\ \(0\)\
\-\ third\\:\\ 0\\.028633847271331333\ \(0\)\
\-\ pressure\\:\\ 0\\.028633847271331333\ \(0\)\
\-\ midline\\:\\ 0\\.028283243086565234\ \(0\)\
\-\ structures\\:\\ 0\\.028257030320917018\ \(0\)\
\-\ meningioma\\:\\ 0\\.028179011636689035\ \(0\)\
\-\ 14\\:\\ 0\\.028076402532207625\ \(0\)\
\-\ developed\\:\\ 0\\.027900592063314376\ \(0\)\
\-\ appears\\:\\ 0\\.02753893821851325\ \(0\)\
\-\ abnormality\\:\\ 0\\.02735387338207853\ \(0\)\
\-\ clear\\:\\ 0\\.02726325337274054\ \(0\)\
\-\ diagnosed\\:\\ 0\\.027240791675116727\ \(0\)\
\-\ ap\\:\\ 0\\.02699863583513855\ \(0\)\
\-\ middle\\:\\ 0\\.026891438320802166\ \(0\)\
\-\ required\\:\\ 0\\.026849042664241537\ \(0\)\
\-\ defined\\:\\ 0\\.026827946640239443\ \(0\)\
\-\ otherwise\\:\\ 0\\.02680691790829424\ \(0\)\
\-\ intensity\\:\\ 0\\.02670276879316318\ \(0\)\
\-\ 24\\:\\ 0\\.026661565522318575\ \(0\)\
\-\ identified\\:\\ 0\\.026661565522318575\ \(0\)\
\-\ then\\:\\ 0\\.026620618174061583\ \(0\)\
\-\ complete\\:\\ 0\\.02636048571886252\ \(0\)\
\-\ cerebral\\:\\ 0\\.02605380242856248\ \(0\)\
\-\ sign\\:\\ 0\\.026035100283040905\ \(0\)\
\-\ headache\\:\\ 0\\.025923988070662096\ \(0\)\
\-\ benign\\:\\ 0\\.02583280401844125\ \(0\)\
\-\ 12\\:\\ 0\\.02570722875738077\ \(0\)\
\-\ elevated\\:\\ 0\\.025636531008802466\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.025601464426787734\ \(0\)\
\-\ areas\\:\\ 0\\.025531885924726418\ \(0\)\
\-\ size\\:\\ 0\\.02546303410437411\ \(0\)\
\-\ unremarkable\\:\\ 0\\.025211060687190555\ \(0\)\
\-\ along\\:\\ 0\\.025194599999799613\ \(0\)\
\-\ central\\:\\ 0\\.025112907481408722\ \(0\)\
\-\ right\\:\\ 0\\.02493590945145673\ \(0\)\
\-\ air\\:\\ 0\\.024597728158857527\ \(0\)\
\-\ injury\\:\\ 0\\.024523067090486014\ \(0\)\
\-\ superior\\:\\ 0\\.02444924210988231\ \(0\)\
\-\ between\\:\\ 0\\.02443457580377764\ \(0\)\
\-\ resection\\:\\ 0\\.024105954051051898\ \(0\)\
\-\ approximately\\:\\ 0\\.023995385390064745\ \(0\)\
\-\ day\\:\\ 0\\.023954395609049245\ \(0\)\
\-\ some\\:\\ 0\\.02366134728095208\ \(0\)\
\-\ yo\\:\\ 0\\.02349411387589397\ \(0\)\
\-\ brain\\:\\ 0\\.023443499409421295\ \(0\)\
\-\ t1\\:\\ 0\\.023430906278801084\ \(0\)\
\-\ cystic\\:\\ 0\\.022648832160737955\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02249422704139153\ \(0\)\
\-\ all\\:\\ 0\\.02238597334667719\ \(0\)\
\-\ time\\:\\ 0\\.022290041958096092\ \(0\)\
\-\ presented\\:\\ 0\\.021929706270953375\ \(0\)\
\-\ fluid\\:\\ 0\\.021712892947112646\ \(0\)\
\-\ enhancement\\:\\ 0\\.021645375878370305\ \(0\)\
\-\ cm\\:\\ 0\\.021597569273839476\ \(0\)\
\-\ than\\:\\ 0\\.021317788878522734\ \(0\)\
\-\ patients\\:\\ 0\\.021155448207988942\ \(0\)\
\-\ more\\:\\ 0\\.02064973238170057\ \(0\)\
\-\ physical\\:\\ 0\\.020390852420449433\ \(0\)\
\-\ acute\\:\\ 0\\.020343424144842536\ \(0\)\
\-\ soft\\:\\ 0\\.02002064979975124\ \(0\)\
\-\ man\\:\\ 0\\.01990909888318201\ \(0\)\
\-\ tissue\\:\\ 0\\.019727275392669212\ \(0\)\
\-\ most\\:\\ 0\\.01957131646222455\ \(0\)\
\-\ mri\\:\\ 0\\.01930359870509776\ \(0\)\
\-\ exam\\:\\ 0\\.018930894007538744\ \(0\)\
\-\ had\\:\\ 0\\.01873670651637448\ \(0\)\
\-\ but\\:\\ 0\\.018596240301005016\ \(0\)\
\-\ findings\\:\\ 0\\.018560083892961456\ \(0\)\
\-\ multiple\\:\\ 0\\.018393927435813168\ \(0\)\
\-\ within\\:\\ 0\\.017320177504314978\ \(0\)\
\-\ be\\:\\ 0\\.015255262718770682\ \(0\)\
\-\ left\\:\\ 0\\.012828236814641226\ \(0\)\
